Understanding Glutaminase: A Potential Drug Target (P37821)

Target Name: Glutaminase

NCBI ID: P37821

Glutaminase

Other Name(s): Glutamine amidohydrolase | GLS | Glutaminase

Understanding Glutaminase: A Potential Drug Target

Glutaminase (nonspecified subtype) (Glutamine amidohydrolase), also known as GLAD, is an enzyme that plays a crucial role in the regulation of protein synthesis and metabolism. The encoded gene for GLAD is located on chromosome 12q24 and has been implicated in a number of cellular processes, including cell signaling, DNA repair, and metabolism.

Glutaminase is a protein that consists of two subunits, alpha-glutamyl transferase (alpha-GT) and gamma-glutamyl transferase (gamma-GT). The alpha-GT subunit is responsible for catalyzing the transfer of alpha-glutamyl groups from the amino acid glutamine to other amino acids, while the gamma-GT subunit is responsible for catalyzing the transfer of gamma-glutamyl groups from the amino acid glutamine to other amino acids.

In cellular metabolism, Glutaminase is involved in the regulation of a wide range of protein synthesis and degradation processes. For example, Glutaminase is involved in the regulation of protein synthesis by initiating the process of protein synthesis by promoting the formation of a membraneless precursor protein.

In addition to its role in protein synthesis, Glutaminase is also involved in the regulation of DNA repair. When DNA is damaged, Glutaminase can help to repair the damage by catalyzing the formation of a new DNA fragment.

Glutaminase is also involved in the regulation of metabolism by promoting the breakdown of damaged or unnecessary proteins. This helps to remove these unwanted proteins, which can be harmful to the body.

Despite its involvement in a wide range of cellular processes, Glutaminase is not well understood. little is known about the structure and function of this enzyme, and much research is needed to fully understand its role in cellular metabolism.

As a result, Glutaminase is an attractive drug target and a potential biomarker for a variety of diseases. Researchers are currently working to develop new treatments for a range of diseases that are caused by the activity of Glutaminase, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, Glutaminase (nonspecified subtype) is an important enzyme that is involved in a wide range of cellular processes. While much research is still needed to fully understand its role in cellular metabolism, its potential as a drug target makes it an attractive target for the development of new treatments for a variety of diseases.

Protein Name: Glutaminase (nonspecified Subtype)

The "Glutaminase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Glutaminase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets